Medivation, Inc. (NASDAQ:MDVN)

CAPS Rating: 2 out of 5

A biopharmaceutical company engaged in the acquisition, research and development of promising medical technologies.

Recs

0
Player Avatar pchop123 (76.55) Submitted: 8/25/2012 7:21:10 PM : Outperform Start Price: $48.13 MDVN Score: +18.26

Leadership should be rewarded even if they are not profitable YET !!

Report this Post Reply

Featured Broker Partners


Advertisement